Terms: = Prostate cancer AND BIRC3, AIP1, 330, ENSG00000023445, HIAP1, Q13489, MIHC, CIAP2, API2, cIAP2, MALT2, hiap-1, RNF49, HAIP1 AND Diagnosis
65 results:
1. [Clinical study of artificial intelligence-guided image fusion assisted transperineal prostate biopsy].
Hu J; Zhao XD; Zhou YL; Dong N; Ma MF; Chen YH; Sheng ZC; Dong J; He CQ; Xu S
Zhonghua Nan Ke Xue; 2023 Aug; 29(8):729-735. PubMed ID: 38619521
[TBL] [Abstract] [Full Text] [Related]
2. cancer mortality and morbidity among patients with schizophrenia: A hospital-based cohort study, 1992-2020.
Drevinskaite M; Kaceniene A; Patasius A; Stukas R; Germanavicius A; Miseikyte E; Urbonas V; Smailyte G
Acta Psychiatr Scand; 2024 Mar; 149(3):234-243. PubMed ID: 38173088
[TBL] [Abstract] [Full Text] [Related]
3. Screening history and risk of death from prostate cancer: a nested case-control study within the screening arm of the Finnish Randomized Study of Screening for prostate cancer (FinRSPC).
Talala K; Walter S; Taari K; Tammela TLJ; Kujala P; Auvinen A
Cancer Causes Control; 2024 Apr; 35(4):695-703. PubMed ID: 38063980
[TBL] [Abstract] [Full Text] [Related]
4. Cost-Effectiveness Modeling of prostate-Specific Membrane Antigen Positron Emission Tomography with Piflufolastat F 18 for the Initial diagnosis of Patients with prostate cancer in the United States.
Yee CW; Harvey MJ; Xin Y; Kirson NY
Pharmacoeconomics; 2024 Feb; 42(2):231-247. PubMed ID: 37934376
[TBL] [Abstract] [Full Text] [Related]
5. Radiation Therapy Changed the Second Malignancy Pattern in Rectal cancer Survivors.
Ye X; Tan Y; Ma R; Lou P; Yuan Y
Medicina (Kaunas); 2023 Aug; 59(8):. PubMed ID: 37629753
[No Abstract] [Full Text] [Related]
6. Liver Fibrosis Scores and prostate cancer Risk and Mortality in the Atherosclerosis Risk in Communities Study.
Wang A; Lazo M; Lu J; Couper DJ; Prizment AE; Vitolins MZ; Denmeade SR; Joshu CE; Platz EA
Cancer Prev Res (Phila); 2023 Sep; 16(9):523-530. PubMed ID: 37339266
[TBL] [Abstract] [Full Text] [Related]
7. Enzalutamide Monotherapy vs Active Surveillance in Patients With Low-risk or Intermediate-risk Localized prostate cancer: The ENACT Randomized Clinical Trial.
Shore ND; Renzulli J; Fleshner NE; Hollowell CMP; Vourganti S; Silberstein J; Siddiqui R; Hairston J; Elsouda D; Russell D; Cooperberg MR; Tomlins SA
JAMA Oncol; 2022 Aug; 8(8):1128-1136. PubMed ID: 35708696
[TBL] [Abstract] [Full Text] [Related]
8. Multi-institutional Analysis of the Clinical and Genomic Characteristics of Black Patients with Metastatic Hormone-Sensitive prostate cancer.
Freeman MN; Jang A; Zhu J; Sanati F; Nandagopal L; Ravindranathan D; Desai A; Phone A; Nussenzveig R; Jaeger E; Caputo SA; Koshkin VS; Swami U; Basu A; Bilen MA; Agarwal N; Sartor O; Burgess EF; Barata PC
Oncologist; 2022 Mar; 27(3):220-227. PubMed ID: 35274720
[TBL] [Abstract] [Full Text] [Related]
9. Using Competing Risk of Mortality to Inform the Transition from prostate cancer Active Surveillance to Watchful Waiting.
Huang MM; Alam R; Gabrielson AT; Su ZT; Kassiri B; Fletcher SA; Biles MJ; Patel HD; Pavlovich CP; Schwen ZR
Eur Urol Focus; 2022 Sep; 8(5):1141-1150. PubMed ID: 34344628
[TBL] [Abstract] [Full Text] [Related]
10. Nomograms to predict outcomes after
Gafita A; Calais J; Grogan TR; Hadaschik B; Wang H; Weber M; Sandhu S; Kratochwil C; Esfandiari R; Tauber R; Zeldin A; Rathke H; Armstrong WR; Robertson A; Thin P; D'Alessandria C; Rettig MB; Delpassand ES; Haberkorn U; Elashoff D; Herrmann K; Czernin J; Hofman MS; Fendler WP; Eiber M
Lancet Oncol; 2021 Aug; 22(8):1115-1125. PubMed ID: 34246328
[TBL] [Abstract] [Full Text] [Related]
11. Temporal changes in cause-specific death in men with localised prostate cancer treated with radical prostatectomy: a population-based, nationwide study.
Thomsen FB; Garmo H; Brasso K; Egevad L; Stattin P
J Surg Oncol; 2021 Oct; 124(5):867-875. PubMed ID: 34145588
[TBL] [Abstract] [Full Text] [Related]
12. Screening of differentially expressed genes and identification of AMACR as a prognostic marker in prostate cancer.
Fu P; Bu C; Cui B; Li N; Wu J
Andrologia; 2021 Jul; 53(6):e14067. PubMed ID: 33861880
[TBL] [Abstract] [Full Text] [Related]
13. Healthcare services expenditures among prostate cancer patients with and without mood disorders in the United States: A propensity score-matched cross-sectional study.
Alsultan MM; Hincapie AL; Schwartz R; Guo JJ
J Psychosoc Oncol; 2021; 39(2):204-218. PubMed ID: 33280542
[TBL] [Abstract] [Full Text] [Related]
14. Bladder cancer stage and mortality: urban vs. rural residency.
Deuker M; Stolzenbach LF; Collà Ruvolo C; Nocera L; Tian Z; Roos FC; Becker A; Kluth LA; Tilki D; Shariat SF; Saad F; Chun FKH; Karakiewicz PI
Cancer Causes Control; 2021 Feb; 32(2):139-145. PubMed ID: 33230694
[TBL] [Abstract] [Full Text] [Related]
15. Strategy for prostate cancer Patients with Low prostate Specific Antigen Level (2.5 to 4.0 ng/mL).
Chung JH; Yu J; Song W; Kang M; Sung HH; Jeon HG; Jeong BC; Seo SI; Lee HM; Jeon SS
J Korean Med Sci; 2020 Oct; 35(41):e342. PubMed ID: 33107227
[TBL] [Abstract] [Full Text] [Related]
16. Unique Features of prostate cancer in African American and West Indian Patients Including diagnosis of High Grade cancers Using Only Elevated Serum Levels of prostate Specific Antigen.
Seydafkan S; Michl J; Pincus MR
Ann Clin Lab Sci; 2020 Jul; 50(4):504-511. PubMed ID: 32826248
[TBL] [Abstract] [Full Text] [Related]
17. Postdiagnosis Body Mass Index, Weight Change, and Mortality From prostate cancer, Cardiovascular Disease, and All Causes Among Survivors of Nonmetastatic prostate cancer.
Troeschel AN; Hartman TJ; Jacobs EJ; Stevens VL; Gansler T; Flanders WD; McCullough LE; Wang Y
J Clin Oncol; 2020 Jun; 38(18):2018-2027. PubMed ID: 32250715
[TBL] [Abstract] [Full Text] [Related]
18. Patients' education level and treatment modality for prostate cancer in the Finnish Randomized Study of Screening for prostate cancer.
Kilpeläinen TP; Talala K; Taari K; Raitanen J; Kujala P; Pylväläinen J; Tammela TL; Auvinen A
Eur J Cancer; 2020 May; 130():204-210. PubMed ID: 32229417
[TBL] [Abstract] [Full Text] [Related]
19. A protocol for a multicentre, parallel-group, pragmatic randomised controlled trial to evaluate the NEVERMIND system in preventing and treating depression in patients with severe somatic conditions.
Carli V; Wasserman D; Hadlaczky G; Petros NG; Carletto S; Citi L; Dinis S; Gentili C; Gonzalez-Martinez S; Aldo De Leonibus ; Meyer B; Ostacoli L; Ottaviano M; Ouakinin S; Paradiso R; Poli R; Rocha I; Settanta C; Waldmeyer MTA; Valenza G; Scilingo EP
BMC Psychiatry; 2020 Mar; 20(1):93. PubMed ID: 32122315
[TBL] [Abstract] [Full Text] [Related]
20. Trends in the Use of Stereotactic Body Radiotherapy for Treatment of prostate cancer in the United States.
Mahase SS; D'Angelo D; Kang J; Hu JC; Barbieri CE; Nagar H
JAMA Netw Open; 2020 Feb; 3(2):e1920471. PubMed ID: 32022878
[TBL] [Abstract] [Full Text] [Related]
[Next]
